Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283244
Status:
COMPLETED
Last Update Posted:
2017-04-24
First Post:
2006-01-24
Brief Title:
Ph II Gemcitabine Erlotinib and Gemcitabine With ErlotinibElderly Patients W IIIBIV NSCLC
Sponsor:
Organization:
UNC Lineberger Comprehensive Cancer Center